Hansen Carl L. G. has filed 19 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 2106505 shares of AbCellera Biologics Inc. ($ABCL) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | A | Share option (right to buy) | 2106505 | $0.00 | 13,096,837.0000 | 298,875,174 | 19.17% | 0.70% |
| Jan. 1, 2025 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | A | Share option (right to buy) | 2730109 | $0.00 | 10,990,332.0000 | 294,327,532 | 33.05% | 0.93% |
| Nov. 25, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 8,260,223.0000 | 294,851,945 | 0.67% | 0.02% |
| Nov. 25, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,984,009.0000 | 294,851,945 | 0.10% | 0.02% |
| Sept. 20, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 8,316,348.0000 | 289,166,486 | 0.67% | 0.02% |
| Sept. 20, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,927,884.0000 | 289,166,486 | 0.10% | 0.02% |
| May 31, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 8,372,473.0000 | 289,166,486 | 0.67% | 0.02% |
| May 31, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,588,243.0000 | 289,166,486 | 0.10% | 0.02% |
| Feb. 26, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 8,428,598.0000 | 289,166,486 | 0.66% | 0.02% |
| Feb. 26, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,532,118.0000 | 289,166,486 | 0.10% | 0.02% |
| Jan. 14, 2024 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | A | Share option (right to buy) | 2095532 | $0.00 | 8,484,723.0000 | 289,166,486 | 32.80% | 0.72% |
| Nov. 23, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 6,389,191.0000 | 314,827,255 | 0.87% | 0.02% |
| Nov. 23, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,685,993.0000 | 314,827,255 | 0.10% | 0.02% |
| Aug. 24, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 6,445,316.0000 | 314,827,255 | 0.86% | 0.02% |
| Aug. 24, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,629,868.0000 | 314,827,255 | 0.10% | 0.02% |
| May 26, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,573,743.0000 | 314,827,255 | 0.10% | 0.02% |
| May 26, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 6,501,441.0000 | 314,827,255 | 0.86% | 0.02% |
| Feb. 22, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Common Shares | 56125 | $2.70 | 56,364,618.0000 | 314,827,255 | 0.10% | 0.02% |
| Feb. 22, 2023 | AbCellera Biologics Inc. | $ABCL | Hansen Carl L. G. | Chief Executive Officer | M | Share option (right to buy) | 56125 | $0.00 | 6,557,566.0000 | 314,827,255 | 0.85% | 0.02% |